CRISPR Therapeutics AG (LON:0VRQ)
London · Delayed Price · Currency is GBP · Price in USD 56.15
-1.11 (-1.95%)
At close: Aug 1, 2025
Theseus Pharmaceuticals Market Cap
CRISPR Therapeutics AG has a market cap or net worth of 3.89 billion as of August 1, 2025. Its market cap has decreased by -1.62% in one year.
Market Cap
3.89B
Enterprise Value
2.65B
Revenue
29.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
$56.15
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from 451.35M to 3.89B, an increase of 760.77%. That is a compound annual growth rate of 27.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.89B | 44.78% |
| Dec 31, 2024 | 2.68B | -31.26% |
| Dec 29, 2023 | 3.90B | 47.79% |
| Dec 30, 2022 | 2.64B | -38.32% |
| Dec 31, 2021 | 4.28B | -45.95% |
| Dec 31, 2020 | 7.92B | 189.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.60B |
| HSBC Holdings | 160.06B |
| Shell | 159.31B |
| Unilever | 109.82B |
| Rolls-Royce Holdings | 89.38B |
| British American Tobacco p.l.c. | 88.30B |
| Rio Tinto Group | 76.62B |
| RELX PLC | 72.00B |